$3.00
-0.16-5.06%
In chiusura: Sep 11, 5:00 PM EST
$3.21
0.051.58%
Pre-mercato: 4:01 AM EST

DNA X (SONM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
DNA X (SONM) ha pubblicato l'ultima guidance il aprile 25, 2023 per Q1 2023. La società ha previsto un fatturato pari a $25.8M - $25.8M per il periodo.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $5.04 | $10.97 | $5.40 |
| Actual | $-0.91 | $5.01 | $-9.44 | $-4.83 |
| Surprise | — | -0.60% | -186.1% | -189.4% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $16.2M |
| Surprise | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q1 | May 20, 2026 | $5.01 | $5.04 | -0.60 % |
| Q4 | Apr 14, 2026 | $-9.44 | $10.97 | -186.1 % |
| Q3 | Oct 31, 2025 | $-4.83 | $5.40 | -189.4 % |
| Q2 | Aug 8, 2025 | $-14.22 | $0.72 | -2075.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 13, 2024 | $15.02M | $14.78M | 1.64 % |
| Q2 | Aug 9, 2024 | $11.52M | $10.91M | 5.55 % |
| Q1 | May 14, 2024 | $16.78M | $18.00M | -6.80 % |
| Q4 | Mar 27, 2024 | $13.43M | $27.57M | -51.3 % |